Total planned funding: $1,851,130,357
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $1,851,130,357 |
Organizational Types
NGO | $485,806,456 |
University | $369,298,017 |
Unknown | $323,000,179 |
Private Contractor | $302,088,566 |
Own Agency | $122,295,914 |
FBO | $103,028,134 |
Implementing Agency | $71,342,830 |
Host Country Government Agency | $36,470,022 |
Other USG Agency | $35,720,240 |
Multi-lateral Agency | $2,079,999 |
Program Areas
Treatment | $696,305,591 |
Care | $359,262,112 |
Governance and Systems | $314,412,784 |
Prevention | $310,518,823 |
Management and Operations | $94,114,055 |
Testing | $76,516,992 |
Budget Codes
HTXD: Treatment: ARV Drugs | $358,724,192 |
HTXS: Treatment: Adult Treatment | $320,269,929 |
HLAB: Laboratory Infrastructure | $150,774,998 |
HKID: Care: Orphans and Vulnerable Children | $148,437,057 |
HBHC: Care: Adult Care and Support | $141,919,402 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $115,619,070 |
HVMS: Management and Operations | $94,114,055 |
OHSS: Health Systems Strengthening | $87,232,877 |
HVCT: Testing: HIV Testing and Counseling | $76,516,992 |
HVSI: Strategic Information | $76,404,909 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $74,925,798 |
HVOP: Sexual Prevention: Other Sexual Prevention | $72,319,435 |
HVTB: Care: TB/HIV | $58,055,344 |
HMBL: Biomedical Prevention: Blood Safety | $30,109,748 |
HMIN: Biomedical Prevention: Injection Safety | $17,544,772 |
PDTX: Treatment: Pediatric Treatment | $17,311,470 |
PDCS: Care: Pediatric Care and Support | $10,850,309 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$280,192,480
Countries/Regions
FHI 360:
$254,150,340
Countries/Regions
Harvard University:
$153,090,978
Countries/Regions
University of Maryland:
$140,003,197
Countries/Regions